Clinical-genetic and Psychoemotional Peculiarities and the Quality of Life of Patients with Long-term Observation of the Dynamics of the Duodenal Ulcer
DOI:
https://doi.org/10.61841/eg4xnx02Keywords:
Duodenal Ulcer, Risk Factors, Polymorphic Variants of Interleukin Genes, Psychoemotional Status, Quality of Life, Long-term Dynamic ObservationAbstract
The rationale for the present study is explained by a high rate of complications in patients with duodenal ulcers and the necessity to search for the markers of disease development and to study the risk factors. The study is aimed at the evaluation of clinical-genetic and psychoemotional peculiarities and quality of life of patients with duodenal ulcers. The authors examined 231 patients aged 39.8±0.8 years old. The authors evaluated the peculiarities of a social factor with the screening methods, peculiarities of the clinical picture according to the standards, analyzed the polymorphic variants of IL10 (-627С>A; rs1800872) with polymerase chain reaction, and assessed the psychoemotional status and quality of life during a long-term observation after the person-oriented educational program for patients with ulcer disease. The authors revealed the peculiarities of the social factor, the changes in the clinical, endoscopic, and psychoemotional picture of the disease, identified the markers of the development of duodenal ulcerous disease, and registered the improvement of the quality of life. The performance of genetic tests for patients, along with clinical and psychoemotional examinations and positive changes in the quality of life, contribute to the complex approach to a long-term observation of patients with duodenal ulcers.
Downloads
References
[1] Volevach L.V., Gabbasova L.V., Kuramshina O.А., Khustutdinova E.K. et al. Characteristics of genetic
predisposition in patients with duodenal ulcers. Modern issues of science and education. 2017.–№5.
[2] Volevach L.V., Nafikova A.S., Khismatullina G.Y., Kamalova А.А. Results of 5-year-old dynamic outpatient observation of patients with gastric ulcer and duodenal ulcer. Medical journal of Bashkortostan.
2017. №6. С.11-15.
[3] Gabbasova L.V., Volevach L.V., Paltusov A.I., Kryukova A.I. et al., Duodenal ulcer in adolescents.
Monography. Tambov: Consulting company Yucom. 2017. 48 p.
[4] Gabbasova L.V., Khustutdinova E.K., Nurgalieva A.K., Kuramshina O.A. et al. The analysis of
polymorphic variant IL10-627С>A in the samplings of patients with duodenal ulcer. Issues of Kazan
medical school. 2015. № 2 (8). С. 58.
[5] Lazebnik L.B., Tkachenko E.I., Abdulkhakov R.A. et al. Standards of diagnostics and treatment of acid-dependent and Helicobacter pylori-associated diseases. Chronic gastritis. Journal of practicing doctors.
Special addition. 2013. №3.С.12-14.
[6] Lazebnik L.B., Scherbakov P.L. (eds.). Gastroenterology. Adult diseases. Moscow, 2011. 479 p.
[7] Pyatenko Е.А., Sheptulin А.А. Peptic ulcerous disease: did it change its manifestations? Russian journal of
gastroenterology, hepatology, coloproctology. 2017; 27(6):14-19.
[8] Sarsenbaeva А.S., Petukhova Т.P., Fedorenko S.V., Ufimtseva I.V. The effectiveness of the standard triple
first-line eradicative therapy based on esomeprazole and other PPI in patients with H. pylori-associated
gastritis. Russian medical journal. Gastroenterology. 2017.-№17. p. 1215-1219.
[9] Trukhan D.I. Diseases of the Esophagus, Stomach, and Duodenum. Clinical picture, diagnostics, and treatment.
Handbook. М.: SpetsLit, 2014. - 471 p.
[10] Chernin V.V. Diseases of esophagus, stomach, and duodenum. М.: Medical information agency, 2015.
528 p.
[11] Alakkari A., Zullo A., O’Connor H.J. Helicobacter pylori and nonmalignant diseases. Helicobacter 2011;
16(Suppl 1):33-7.
[12] Carli D.M., Pires R.C., Rohde S.L. Peptic ulcer frequency differences related to H. pylori or aines. Arq
Gastroenterol 2015; 52:46-9.
[13] Charpignon C., Lesgourgues B., Pariente A. Peptic ulcer disease: one in five is related to neither
Helicobacter pylori non-aspirin/NSAID intake. Aliment Pharmacol Ther 2013; 38:946-54.
[14] Chung C.S., Chiang T. H., Lee V. C. A systemic approach for the diagnosis and treatment of idiopathic
peptic ulcers. Korean J Intern Med 2015; 30: 559-70.
[15] Datta De D., Roychoudhury S. To be or not to be: The host genetic factor and beyond in Helicobacter
Pylori-mediated gastro-duodenal diseases. World J Gastroenterol. 2015; 21(10): 2883-95.
[16] Eusebi L., Zagari M., Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter 2014; 19
(Suppl 1):1-5.
[17] Ivashkin V.T., Sheptulin A.A., Maev I.V. et al. Clinical recommendations of Russian gastroenterologists
association on the diagnostics and treatment of peptic ulcerous disease. Russian journal of
gastroenterology, hepatology, and coloproctology 2016; 26(6):40-54.
[18] Khatoon J., Prasad K.N., Rai R.P., Shukla S.K., Krishnani N., Ghoshal U.C. Expression levels of A disintegrin and metalloproteases (ADAMs), and Th17-related cytokines and their association with Helicobacter pylori infection in patients with gastroduodenal diseases. Pathog Dis. 2018; 76(8).
[19] Malfertheiner P., Megraud F., O’Morain C., et al. Management of Helicobacter pylori infection: the Maastricht-Florence Consensus Report // Gut Online First, published on October 5, 2016 as 10.1136/gutjnl-2016-312288.
[20] Matsuda, K. Possible role of genetic factors on reduced risk for gastric cancer among duodenal ulcer
patients / K. Matsuda, C. Tanikawa, Y. Nakamura // Nihon Rinsho. – 2013. – Vol. 71, № 8. – P. 1491-6.
[21] Miftahussurur M., Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk
factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015; 9(12): 1535-47.
[22] Miyamoto, M. Gastric ulcer and duodenal ulcer / M. Miyamoto, K. Haruma // Nihon Rinsho. – 2013.
Vol. 71, № 8. P. 1418-23.
[23] Nishizawa T., Nishizava Y., Yahagi N. Effect of supplementation with rebamipide for Helicobacter pylori
Eradication therapy: A systematic review and meta-analysis. J Gastroenterol Hepatol 2014; 29(1).
4):20-4.
[24] Nurgalieva A.Kh., Shaymardanova E.Kh., Khidiyatova I.M., Nadyrshina D.D., Gabbasova L.V.,
Kuramshina O.A., Krukova A.Y., Khusnutdinova E.K. Association of cytokine gene polymorphisms
in peptic ulcer development in the Bashkortostan Republic. Genetika. 2014; 50(12): 1455-65.
[25] Ramis I.B., Vianna J.S., Gonçalves C.V., von Groll A., Dellagostin O.A., da Silva PEA. Polymorphisms of
the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter
Pylori. J Microbiol Immunol Infect. 2017; 50(2):153-159.
[26] Rezaeishahmirzadi M., Motamedi Rad N., Kalantar M., Ayatollahi H., Shakeri S., Sheikhi M., Shekari M.
The Association of Gastritis and Peptic Ulcer With Polymorphisms in the Inflammatory-related Genes IL-4
and IL-10 in the Iranian population. Iran J Pathol. 2018; 13(2): 229-236.
[27] Sheptulin A.A., Lapina T.L., Kaybysheva V.O. Update on Helicobacter pylori infection study and key
points of the «Maastricht-V» consensus conference (2016). Rus J. Gastroenterol. Hepatol. Coloproctol. 2017;27(1):35-43.
[28] Shung C.-S., Chiang T.-H., Lee Y.-C. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Interm Med 2015; 30:559-70.
[29] Tsimmerman Ya.S. Gastroenterologiya. M.: GEOTAR Media; 2012.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
